Allopregnanolone concentrations and premenstrual syndrome

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor

Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225

Neurosteroids: Endogenous bimodal modulators of the GABAA receptor mechanism of action and physiological significance

Majewska, M. D. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90025-a · Cited by 1,089

Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome

Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380401 · Cited by 765

GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid

Smith, S. S., Gong, Q. H., Hsu, F.-C., Markowitz, R. S., ffrench-Mullen, J. M. H., & Li, X. (1998) · Nature · doi:10.1038/31948 · Cited by 564

Circulating Levels of Allopregnanolone in Humans: Gender, Age, and Endocrine Influences

Genazzani, A. R., Petraglia, F., Bernardi, F., Casarosa, E., Salvestroni, C., Tonetti, A., Nappi, R. E., Luisi, S. V., Palumbo, M. A., Purdy, R. H., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4905 · Cited by 392

Progesterone metabolite allopregnanolone in women with premenstrual syndrome

RAPKIN, A., MORGAN, M., GOLDMAN, L., BRANN, D., SIMONE, D., & MAHESH, V (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00417-1 · Cited by 376

Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha- pregnan-20-one

Wang, M., Seippel, L., Purdy, R. H., & Bäckström, T. C. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772579 · Cited by 353

Mood, Sexuality, Hormones, and the Menstrual Cycle. II. Hormone Levels and Their Relationship to the Premenstrual Syndrome

Bäckström, T. C., Sanders, D., Leask, R., Davidson, D., Warner, P., & Bancroft, J. (1983) · Psychosomatic Medicine · doi:10.1097/00006842-198312000-00004 · Cited by 266

Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects

Rubinow, D. R., Hoban, M. C., Grover, G. N., Galloway, D. S., Roy-Byrne, P., Andersen, R., & Merriam, G. R. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90765-x · Cited by 235

Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects

Schmidt, P. J., Purdy, R. H., Moore, P. H., Paul, S. M., & Rubinow, D. R. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962316 · Cited by 185

Effect of tibolone administration on central and peripheral levels of allopregnanolone and β-endorphin in female rats

Genazzani, A. R., Bernardi, F., Pluchino, N., Giretti, M. S., Begliuomini, S., Casarosa, E., Luisi, M., & Kloosterboer, H. J. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000191372.79052.d3 · Cited by 28

Contraceptive options for women with premenstrual dysphoric disorder: current insights and a narrative review

Lete, I., & Ocamica, O. L. (2016) · Open Access Journal of Contraception · doi:10.2147/oajc.s97013 · Cited by 27

Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS

Genazzani, A. D., Chierchia, E., Rattighieri, E., Santagni, S., Casarosa, E., Luisi, M., & Genazzani, A. R. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.500818 · Cited by 25

Effect of zinc supplementation on quality of life and sleep quality in young women with premenstrual syndrome: a randomized, double-blind, placebo-controlled trial

Jafari, F., Tarrahi, M. J., Farhang, A., & Amani, R. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05628-w · Cited by 25

Effect of an Oral Contraceptive with Chlormadinone Acetate on Depressive Mood

Huber, J. C., Heskamp, M. ‐. S., & Schramm, G. A. K. (2008) · Clinical Drug Investigation · doi:10.2165/0044011-200828120-00006 · Cited by 25

Neurosteroids – From Basic Research to Clinical Perspectives

Frye, C. A. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00086-3 · Cited by 24

Plastic neuronal changes in GABAA receptor gene expression induced by progesterone metabolites: In vitro molecular and functional studies

Biggio, F., Gorini, G., Caria, S., Murru, L., Mostallino, M. C., Sanna, E., & Follesa, P. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.002 · Cited by 23

Antinociceptive profile of ring A-reduced progesterone metabolites in the formalin test

Ocvirk, R., Murphy, B. E. P., Franklin, K. B. J., & Abbott, F. V. (2008) · Pain · doi:10.1016/j.pain.2008.01.019 · Cited by 22

Increased Response of Plasma Allopregnanolone to Corticotropin-Releasing Hormone in Obese Patients

Menozzi, R., Florio, P., Bondi, M., Luisi, S. V., Cobellis, L., Genazzani, A. R., Rio, G. D., & Petraglia, F. (2002) · Neuroendocrinology · doi:10.1159/000048228 · Cited by 22

Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women

Florio, P., Quirici, B., Casarosa, E., Lombardi, I., Luisi, M., Genazzani, A. D., Petraglia, F., & Genazzani, A. R. (2001) · Gynecological Endocrinology · doi:10.1080/713602927 · Cited by 22

Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development

Gao, Q., Sun, W., Wang, Y.-R., Li, Z., Zhao, F., Geng, X., Xu, K., Chen, D., Liu, K., Xing, Y., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1140796 · Cited by 25

A high-performance liquid chromatography–tandem mass spectrometry assay of the androgenic neurosteroid 3α-androstanediol (5α-androstane-3α,17β-diol) in plasma

Reddy, D., Venkatarangan, L., Chien, B., & Ramu, K. (2005) · Steroids · doi:10.1016/j.steroids.2005.05.007 · Cited by 14

Advances in neurosteroids: role in clinical practice

Pluchino, N., Santoro, A. N., Casarosa, E., Wenger, J. M., Genazzani, A. D., Petignat, P., & Genazzani, A. R. (2013) · Climacteric · doi:10.3109/13697137.2013.809647 · Cited by 20

Allopregnanolone: The missing link to explain the effects of stress on tic exacerbation?

Bortolato, M., Coffey, B. J., Gabbay, V., & Scheggi, S. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13022 · Cited by 20

Mood disorders and hormonal status across women’s life: a narrative review

Antonelli, A., Giannini, A., Chedraui, P. A., Monteleone, P., Caretto, M., Genazzani, A. D., Mannella, P., Simoncini, T., & Genazzani, A. R. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2149730 · Cited by 19

GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder

Miller, K. N., Standeven, L. R., Morrow, A. L., Payne, J. L., Epperson, C. N., & Hantsoo, L. V. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106684 · Cited by 19

GABAA dysregulation as an explanatory model for late-onset postpartum depression associated with weaning and resumption of menstruation

Burke, C. S., Susser, L. C., & Hermann, A. D. (2018) · Archives of Women s Mental Health · doi:10.1007/s00737-018-0871-9 · Cited by 19

Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women

Hedström, H., Bixo, M., Nyberg, S., Spigset, O., Zingmark, E., & Bäckström, T. C. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1372-8 · Cited by 19

The efficacy of lemon balm (Melissa officinalis L.) alone and combined with lemon balm—Nepeta menthoides on premenstrual syndrome and quality of life among students: A randomized controlled trial

Mirghafourvand‬‬‬‬‬‬‬‬‬‬‬‬‬‬, M., Malakouti, J., Mohammad‐Alizadeh‐Charandabi, S., Khalili, A. F., & Homayi, S. G. (2016) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2016.07.001 · Cited by 18

A sensitive and accurate LC-MS/MS assay with the derivatization of 1-Amino-4-methylpiperazine applied to serum allopregnanolone, pregnenolone and androsterone in pre- and postmenopausal women

Ke, Y., Gonthier, R., & Labrie, F. (2016) · Steroids · doi:10.1016/j.steroids.2016.11.007 · Cited by 16

Progesterone increase under DHEA-substitution in males

Nadjafi-Triebsch, C., Hüell, M., Burki, D., & Rohr, U. D. (2003) · Maturitas · doi:10.1016/s0378-5122(03)00147-6 · Cited by 15

Neurosteroids; potential underpinning roles in maintaining homeostasis

Rahmani, B., Ghasemi, R., Dargahi, L., Ahmadiani, A., & Haeri, A. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.09.030 · Cited by 14

Increased anxiety‐like phenotype in female guinea pigs following reduced neurosteroid exposure in utero

Cumberland, A. L., Palliser, H. K., Crombie, G. K., Walker, D. W., & Hirst, J. J. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.02.001 · Cited by 13

Mental and Reproductive Health Correlates of Academic Performance among Debre Berhan University Female Students, Ethiopia: The Case of Premenstrual Dysphoric Disorder

Alemu, S. M., Habtewold, T. D., & Haile, Y. G. (2017) · BioMed Research International · doi:10.1155/2017/9348159 · Cited by 15

Luteal Phase and Symptom-Onset Dosing of SSRIs/SNRIs in the Treatment of Premenstrual Dysphoria: Clinical Evidence and Rationale

Steiner, M. S., & Li, T. (2013) · CNS Drugs · doi:10.1007/s40263-013-0069-7 · Cited by 12

Altered visual cortex excitability in premenstrual dysphoric disorder: Evidence from magnetoencephalographic gamma oscillations and perceptual suppression

Manyukhina, V. O., Orekhova, E. V., Prokofyev, A. O., Obukhova, T. S., & Stroganova, T. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0279868 · Cited by 12

Premenstrual Syndrome

Chocano-Bedoya, P. O., & Bertone‐Johnson, E. R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384978-6.00013-3 · Cited by 11

Anxiety-like Behavior and GABAAR/BDZ Binding Site Response to Progesterone Withdrawal in a Stress-Vulnerable Strain, the Wistar Kyoto Rats

Islas-Preciado, D., Ugalde-Fuentes, G., Sollozo-Dupont, I., González-Trujano, M. E., Cervantes-Anaya, N., Estrada-Camarena, E. M., & López‐Rubalcava, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137259 · Cited by 11

Evaluation of the Effect of Acute Sibutramine in Female Rats in the Elevated T-Maze and Elevated Plus-Maze Tests

Santos, R. O., Assunção, G. L. M. D., de Medeiros, D. M. B., Pinto, Í. A. D. S., de Barros, K. S., Soares, B. L., Andrè, E., Gavioli, E. C., & Soares-Rachetti, V. D. P. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12131 · Cited by 10

Neuroactive Steroid Biomarkers of Alcohol Sensitivity and Alcoholism Risk

Morrow, A. L., & Porcu, P. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9838-3_4 · Cited by 10

Current perspectives on the role of neurosteroids in PMS and depression

Griffin, L. D., Conrad, S. C., & Mellon, S. H. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46073-9 · Cited by 10

Anxiety sensitivity as a moderator of the association between premenstrual symptoms and posttraumatic stress disorder symptom severity.

Nillni, Y. I., Berenz, E. C., Pineles, S. L., Coffey, S. F., & Zvolensky, M. J. (2013) · Psychological Trauma Theory Research Practice and Policy · doi:10.1037/a0032087 · Cited by 9

Impact of anger emotional stress before pregnancy on adult male offspring

Wei, S., Xiao, X., Wang, J., Sun, S., Li, Z., Xu, K., Li, F., Gao, J., Zhu, D., & Qiao, M. (2017) · Oncotarget · doi:10.18632/oncotarget.22007 · Cited by 10

Cardiovascular Autonomic Profile in Women With Premenstrual Syndrome

Koifman, R., Dayan, L., Ablin, J. N., & Jacob, G. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01384 · Cited by 9

Synthesis, Enzyme Localization, and Regulation of Neurosteroids

Smith, S. S. (2003) · CRC Press eBooks · doi:10.1201/9780203508169.ch1 · Cited by 9

Clinical implications of circulating neurosteroids

Genazzani, A. R., Monteleone, P., Stomati, M., Bernardi, F., Cobellis, L., Cosarosa, E., Luisi, M., Luisi, S. V., & Petraglia, F. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46070-3 · Cited by 8

Influence of endometrial nerve fibers and hormones on pain in women with endometriosis

Sommar, A., Bahat, P. Y., Özaydin, I. Y., Bixo, M., Bäckström, T. C., Oral, E., & Türkmen, Ş. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.113950 · Cited by 7

Ovarian Hormones

Hobeika, E. M., Armouti, M., Kala, H. S., & Stocco, C. O. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813814-4.00025-0 · Cited by 7

Gonadotropin-releasing hormone-stimulated gonadotropin levels in women with premenstrual dysphoria

Smith, M., Schmidt, P., Su, T.-P., & Rubinow, D. (2004) · Gynecological Endocrinology · doi:10.1080/09513590400018199 · Cited by 7

Menstrually-related mood disorders and postpartum depression: Convergent aspects in aetiology

Islas-Preciado, D., Estrada-Camarena, E. M., & Galea, L. A. M. (2024) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2024.101171 · Cited by 8

“Rapid actions of the neurosteroid allopregnanolone on ovarian and hypothalamic steroidogenesis: Central and peripheral modulation”

Cáceres, A. R. R., Orozco, A. S. V., Cabrera, R., & Laconi, M. R. (2020) · Journal of Neuroendocrinology · doi:10.1111/jne.12836 · Cited by 6

Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety

Macdougall, M., & Steiner, M. S. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.2.161 · Cited by 6

Profiling GABA(A) Receptor Subunit Expression in the Hippocampus of PMDD Rat Models Based on TCM Theories

Zhang, H., Gao, Z., Sun, Y., Lu, T., Wang, Z., Gao, D., Wang, J., Qiao, M., & Gao, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03354-3 · Cited by 5

Premenstrual Dysphoric Disorder

Poromaa, I. S. (2003) · Frontiers in neuroscience · doi:10.1201/9780203508169.ch13 · Cited by 5

Alcohols which have been in contact with any plastics may interfere in radioimmunoassays of progesterone

Ocvirk, R., Bisson, J. M., & Murphy, B. E. P. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.10.009 · Cited by 4

Neuroactive Steroids and Depression

Miller, K. K. (2018) · Springer eBooks · doi:10.1007/978-3-319-97241-1_11 · Cited by 4

Early postnatal allopregnanolone levels alteration and adult behavioral disruption in rats: Implication for drug abuse

Bartolomé, I., Llidó, A., Darbra, S., & Pallarés, M. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100208 · Cited by 4

Gonadal Hormones and Behavior in Women: Concentrations versus Context

Rubinow, D. R., Schmidt, P. J., Meltzer-Brody, S. E., & Harsh, V. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00076-0 · Cited by 4

Action of Progesterone and Progesterone Metabolites in Menstrual‐Cycle–Related Disorders

Poromaa, I. S. (2008) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01201.x · Cited by 4

Micronutrient Intake and Premenstrual Syndrome

Chocano-Bedoya, P. O. (2022) · ScholarWorks@UMassAmherst (University of Massachusetts Amherst) · doi:10.7275/2387359 · Cited by 4

PROGESTERONE ORGANOGEL FOR PREMENSTRUAL DYSPHORIC DISORDER

Shippen, E. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200103000-00002 · Cited by 4

Impact of premenstrual syndrome and premenstrual dysphoric disorder on maternal antenatal depression

Ihara, N., Sato, Y., Ikeda, S., Matsufuji, H., Kikuchi, K., Suetsugu, Y., Hikita, N., & Morokuma, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0315628 · Cited by 3

Obesity and Metabolic Syndrome: Impact and Relationship with Menopausal Transition

Santagni, S., Rattighieri, E., Chierchia, E., Despini, G., Prati, A., & Genazzani, A. D. (2014) · ISGE series · doi:10.1007/978-3-319-09662-9_16 · Cited by 3

Metabolic Changes and Metabolic Syndrome During the Menopausal Transition

Genazzani, A. D., Prati, A., & Despini, G. (2018) · ISGE series · doi:10.1007/978-3-319-63540-8_12 · Cited by 3

Management of premenstrual dysphoric disorder

Brechin, S. J. G., & Owen, P. (2003) · Hospital Medicine · doi:10.12968/hosp.2003.64.6.348 · Cited by 3

Gonadal Hormones and Behavior in Women

Rubinow, D. R., Schmidt, P. J., Roca, C. A., & Daly, R. C. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50086-x · Cited by 3

PROGESTERONE ORGANOGEL FOR PREMENSTRUAL DYSPHORIC DISORDER

Capps, S. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200103000-00001 · Cited by 3

Metabolic Changes at the Menopausal Transition

Caretto, M., Giannini, A., Palla, G., & Simoncini, T. (2021) · ISGE series · doi:10.1007/978-3-030-63650-0_16 · Cited by 2

Polycystic Ovary Syndrome: From Contraception to Hormone Replacement Therapy

Genazzani, A. R., & Genazzani, A. D. (2014) · ISGE series · doi:10.1007/978-3-319-09662-9_3 · Cited by 2

Anticipation and consumption of food each increase the concentration of neuroactive steroids in rat brain and plasma

Pisu, M. G., Floris, I., Maciocco, E., Serra, M., & Biggio, G. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.011 · Cited by 2

Parallel Session Abstracts

Kesmodel, U. S., Bertrand, J., Støvring, H., Skarpness, B., Denny, C. H., Mortensen, E. L., Bakketeig, L. S., Boyle, C. A., Cogswell, M. E., Eriksen, H. F., et al. (2012) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2012.01435_1.x · Cited by 2

The Role of Progesterone and its Metabolites in Premenstrual Disorders of Affect

Dohi, A., Dillon, G. H., & Singh, M. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6854-6_23 · Cited by 2

The effect of nutritional supplementation on premenstrual syndrome

Avila, C. (2009) · Cross Connect (Southern Cross University) · Cited by 2

Reproductive Hormones and Stages of Life in Women: Moderators of Mood and Cardiovascular Health

Girdler, S. S., & Light, K. C. (2010) · Springer eBooks · doi:10.1007/978-0-387-09488-5_38 · Cited by 1

Therapeutic patents for the treatment of premenstrual syndrome and premenstrual dysphoric disorder: historical perspectives and future directions

Ross, L. E., & Steiner, M. S. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.10.1491 · Cited by 1

Neuroactive steroid levels are elevated in the follicular phase and predict premenstrual depression and anxiety symptom severity in women with menstrually related mood disorder

Kimball, A., Bourassa, J. G., Chicote, M. L., Gerweck, A. V., Dichtel, L. E., & Miller, K. K. (2024) · Archives of Women s Mental Health · doi:10.1007/s00737-024-01532-3 · Cited by 1

月経随伴症状 —機能性 (原発性) 月経困難症と月経前症候群/月経前不快気分障害—

江川, 美. (2020) · 心身医学 · doi:10.15064/jjpm.60.6_515 · Cited by 1

Premenstrual dysphoric disorder in relation to neuroactive steroids and alcohol

Nyberg, S. (2006) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1

Author’s Response: Allopregnanolone Assays

Petraglia, F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7352-2 · Cited by 1

Neurosteroids

Genazzani, A. R., Bernardi, F., Liut, M., Stomati, M., Pieri, M., & Luisi, M. (2002) · Medical science symposia series · doi:10.1007/978-1-4615-1061-1_32 · Cited by 1

Ormoni, psiche e modulazione dell’umore: quando il ginecologo conta

Valentino, V., Bernardi, F., Pluchino, N., & Genazzani, A. R. (2006) · CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche)

Psychiatric disorders of menses, pregnancy, postpartum and menopause

Buist, A., Yonkers, K. A., & Craig, M. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544125.020

Toremifene in premenstrual mastalgia

Oksa, S. (2013) · Tampere University Institutional Repository (Tampere University)

Neurosteroids in clinical practice: implications for women’s health

Genazzani, A. R., Bucci, F., Russo, N., Daino, D., Santoro, A. N., & Pluchino, N. (2011) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2011.120

Premenstrual disphoric disorder: an update

Banti, S., Borri, C., Montagnani, Cargioli, C., Belli, S. R., Cotugno, B., Endicott, J., Oppo, A., & Mauri, M. (2012) · CINECA IRIS Institutial research information system (University of Pisa)

Menopausal changes of ovaries and hypothalamic–pituitary and cerebral function

Genazzani, A. D., Bernardi, F., Pluchino, N., Ceccarelli, C., & Luisi, M. (2005) · CRC Press eBooks · doi:10.3109/9780203486122-5

PRIEŠMENSTRUACINIO SINDROMO PAPLITIMAS TARP HORMONINĘ KONTRACEPCIJĄ NAUDOJANČIŲ IR NENAUDOJANČIŲ MOTERŲ

Stankovskaja, J., & Bumbulienė, Ž. (2017) · Sveikatos mokslai · doi:10.5200/sm-hs.2017.020

GABA-steroid effects in healthy subjects and women with polycystic ovary syndrome

Hedström, H. (2011) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Endogenous and Synthetic Neurosteroids in the Treatment of Niemann–Pick Type C Disease

Mellon, S. H., Gong, W., & Schonemann, M. D. (2011) · Wiley eBooks · doi:10.1002/9783527633968.ch4

Tolerance and antagonism to allopregnanolone effects in the rat CNS

Türkmen, Ş. (2006) · DiVA at Umeå University (Umeå University)

The interaction of sleep and hormones on emotion functioning

Lustig, K. A. (2021) · Brock University Digital Repository (Brock University)

Mindfulness-Based Cognitive Therapy for Coping with Premenstrual Syndrome Distress

Gupta, K., Parimal, B. S., & Patel, A. K. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5088-8.ch010

Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry

Scott, H. C., Philpott, M., Berridge, G., Yu, Z., O'Brien, D. P., Becker, C., Lindgren, C. M., Oppermann, U. C. T., Müller, J., Fritsch, M., et al. (2025) · Journal of Endocrinology and Metabolism · doi:10.14740/jem1042

Estrogens and Other Hormones in the Treatment of Premenstrual Syndromes

Born, L., & Steiner, M. S. (2005) · Springer eBooks · doi:10.1007/3-211-27063-9_8

Premenstrual disorders

Tiwari, A., Lu, D., Chocano-Bedoya, P. O., & Bertone-Johnson, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00024-x

CLINICAL STUDY Allopregnanolone concentrations and premenstrual syndrome

Monteleone, P., Luisi, S., Tonetti, A., Bernardi, F., Genazzani, R. D., Luisi, M., Petraglia, F., & Genazzani, A. R. (2015)

Progesterone metabolite allopregnanolone in women with premenstrual syndrome

RAPKIN, A., MORGAN, M., GOLDMAN, L., BRANN, D., SIMONE, D., & MAHESH, V (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00417-1 · Cited by 376

Allopregnanolone in Women with Premenstrual Syndrome

Bičı́ková, M., DIBBELT, L., Hiill, M., Hampl, R., & Stárka, L. (1998) · Hormone and Metabolic Research · doi:10.1055/s-2007-978871 · Cited by 96

Premenstrual Syndrome. A Message from Preventive Medicine and Your Physician

(2001) · Preventive Medicine · doi:10.1006/pmed.2001.0886

Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome

Lombardi, I., Luisi, S. V., Quirici, B., Monteleone, P., Bernardi, F., Liut, M., Casarosa, E., Palumbo, M. A., Petraglia, F., & Genazzani, A. R. (2004) · Gynecological Endocrinology · doi:10.1080/09513590310001652955 · Cited by 61